Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation

Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis

(2016) Akiyuki Uzawa et al.   CLINICA CHIMICA ACTA

Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses

(2016) Yusuf A Rajabally et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency

(2015) Bruria Ben-Zeev et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities

(2015) Dror Mevorach   MOLECULAR IMMUNOLOGY

Early-onset chronic axonal neuropathy, strokes, and hemolysis: Inherited CD59 deficiency

(2015) G. Haliloglu et al.   NEUROLOGY

Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59

(2014) Hua Zhang et al.   JOURNAL OF AUTOIMMUNITY

Targeted Therapy with Eculizumab for Inherited CD59 Deficiency

(2014) Britta Höchsmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombosis in paroxysmal nocturnal hemoglobinuria

(2013) A. Hill et al.   BLOOD

CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy

(2012) Y. Nevo et al.   BLOOD

First-line treatment for CIDP: a new piece of the puzzle

(2012) Ivo N van Schaik   LANCET NEUROLOGY

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

(2012) Eduardo Nobile-Orazio et al.   LANCET NEUROLOGY

Guillain–Barré Syndrome

(2012) Nobuhiro Yuki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Constitutive Neutrophil Apoptosis: Regulation by Cell Concentration via S100 A8/9 and the MEK – ERK Pathway

(2012) Mizhir Atallah et al.   PLoS One

Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition

(2010) Jean-Michel Vallat et al.   LANCET NEUROLOGY

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice

(2009) Kay N. Greenshields et al.   JOURNAL OF CLINICAL INVESTIGATION

A Novel Model to Measure the Regenerative Potential of the Peripheral Nervous System after Experimental Immunological Demyelination

(2009) Aaron M. Kosins et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model

(2008) Susan K. Halstead et al.   BRAIN